Clinically Meaningful Explainability for NeuroAI: An ethical, technical, and clinical perspective

Technical Deep Dive: Clinically Meaningful Explainability for NeuroAI

Overview

This technical deep-dive examines the concept of "clinically meaningful explainability" (CME) for AI systems in the domain of neurotechnology (NeuroAI). The key points are:

• Explainability is often touted as a requirement for trustworthy medical AI, but its real-world implementation in neurotechnology remains low.
• Existing XAI methods often fail to align with clinicians' needs for actionable, context-aware explanations that support safe and responsible decision-making.
• The authors propose the concept of CME, which reframes explainability as an instrumental property oriented toward clinical reasoning and patient well-being, rather than just algorithmic transparency.
• A tri-dimensional model is introduced that integrates the clinical, technical, and ethical requirements for implementing CME in NeuroAI systems.
• Operationalizing CME requires coordinated efforts in design, validation, and governance to ensure explainability serves the needs of clinicians and patients.

Problem & Context

• Neurotechnology encompasses therapeutic and diagnostic tools that interact with the nervous system, including implantable and non-implantable devices.
• Closed-loop neurotechnology leverages adaptive stimulation paradigms that modulate parameters based on neural signals and other triggers.
• In these closed-loop systems, the explainability of AI components is reportedly important to stakeholders like clinicians, patients, developers, and regulators.
• However, the real-world adoption of XAI methods in clinical neurotechnology remains low, despite the widespread normative endorsement of explainability.
• This discrepancy may reflect a conceptual misalignment: existing XAI approaches were designed to expose algorithmic structure, not to support clinical reasoning or patient care.

Defining Clinically Meaningful Explainability (CME)

• CME is defined as the capacity of an AI system to provide end-users, particularly clinicians and patients, with explanations that are interpretable, actionable, and relevant within clinical reasoning.
• CME differs from conventional explainability in three key ways:
  1. Purpose alignment: CME is oriented toward clinical decision support, not just algorithmic transparency.
  2. Cognitive fit: CME emphasizes interpretive formats corresponding to clinicians' workflow, knowledge, and intuitions.
  3. Ethical adequacy: CME explicitly integrates values like autonomy, accountability, and non-maleficence.
• CME cannot be engineered at the algorithmic level alone; it must emerge from co-design between clinicians, engineers, ethicists, and patients.

A Tri-Dimensional Model for CME in NeuroAI

The authors propose a tri-dimensional model for implementing CME, comprising:

1. The Clinical Dimension (Actionable Interpretability):
   • Clinicians require explanations that are actionable, context-aware, and integrated into clinical reasoning.
   • Representations should link algorithmic inferences to medically meaningful categories like symptom trajectories and stimulation efficacy.
2. The Technical Dimension (Computational Fidelity):
   • Interpretable outputs must not compromise the predictive accuracy, stability, or latency of the underlying model.
   • Fidelity-preserving mechanisms like post-hoc feature attribution are needed.
3. The Ethical Dimension (Value Alignment and Accountability):
   • Explanations must be accessible to all stakeholders, including patients, without undue cognitive burden or false confidence.
   • Responsibility must remain traceable, with clear boundaries between human and algorithmic agency.

Operationalizing CME in Practice

Translating CME into practice requires coordinated efforts across three domains:

1. Design: Explainability should be co-constitutive with system design, not a post-hoc feature. Iterative co-design with clinicians and patients is crucial.
2. Validation: Current AI evaluation pipelines must be expanded to assess the cognitive and practical utility of explanations, not just their technical fidelity.
3. Governance: Regulators should establish explainability sufficiency criteria tailored to clinical contexts, and continuous monitoring mechanisms should be put in place.

Conclusion

Clinically meaningful explainability reframes transparency as a clinical virtue that enables informed action, preserves professional judgment, and aligns the logic of machines with the values of medicine. Operationalizing CME is essential for realizing the promise of NeuroAI in a way that is socially aligned and ethically robust.